Ticagrelor alone

ApprovedSmall molecule

UUniversity Hospital, Bordeaux

Ticagrelor alone is one of 40 small molecule programs targeting Angina Pectoris. It is currently in Approved.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Angina PectorisActive, not recruiting

Aortic Valve StenosisTerminated

Angina PectorisApproved

Active, not recruiting

Aortic Valve StenosisPhase 3

Terminated

Competition

Competitive Landscape

69 competitors in Angina Pectoris

#DrugCompanyPhaseTrials

Bayer Aspirin

Bayer

Approved

2 2

Brilinta

AstraZeneca

Approved

1 3

Prevacid

Adenocard

Diabeta

Zyloprim

Alnylam Pharmaceuticals

Plavix

Thalitone

Alnylam Pharmaceuticals

Isordil

Multaq

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Angina Pectoris1 trial

Influence of METHoxyflurane on ANtiplatelet Effect of Ticagrelor in Patients With Unstable Angina Pectoris

Completed·CCollegium Medicum w Bydgoszczy·Phase 4·NCT04442919·72 enrolled

Aortic Valve Stenosis1 trial

Safety Profile Evaluation of TICagrelor Alone Compared to a Combination of Lysine Acetylsalicylate-Clopidogrel in the Context of Transcatheter Aortic Valve Implantation (TAVI)

Terminated·UUniversity Hospital, Bordeaux·Phase 3·NCT02817789·50 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Ticagrelor alone. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Ticagrelor alone compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Ticagrelor alone. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — University Hospital, Bordeaux company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: UUniversity Hospital, Bordeaux

Ticagrelor alone

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Angina Pectoris1 trial

Aortic Valve Stenosis1 trial

References

Drug Info

Quick Facts

Related News